Geron Corporation to Present at BIO CEO Conference.Business Editors/Health/Medical Writers MENLO PARK Menlo Park. 1 Residential city (1990 pop. 28,040), San Mateo co., W Calif.; inc. 1874. Electronic equipment and aerospace products are manufactured in the city. Menlo College and a Stanford Univ. research institute are there. 2 Uninc. , Calif.--(BUSINESS WIRE)--Feb. 20, 2004 Geron Corporation (Nasdaq:GERN v. t. 1. To grin or yawn. ) will be presenting a company overview on Tuesday, February 24, 2004, at the Biotechnology Industry Organization's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Investor Conference at 2:30 p.m., Eastern Time. The presentation will highlight the company's current product development efforts within oncology and human embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. therapies. The review of Geron's portfolio of telomerase-based anti-cancer therapies will include an update on GRN GRN Green GRN Green (Political) Party GRN Global Recycling Network GRN Gulf Restoration Network (New Orleans, LA) GRN Goods Received Note GRN Global Reference Network (GPS) 163 and GRN163L and progress on the ex vivo ex vivo /ex vi·vo/ (eks´ ve´vo) outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site. telomerase telomerase /telo·mer·ase/ (te-lo´mer-as) a DNA polymerase involved in the formation of telomeres and the maintenance of telomere sequences during replication. te·lom·er·ase n. vaccine. The presentation will also include updates on the company's latest human embryonic stem cell (hESC) research in spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. , diabetes and heart disease. Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer, will be giving the presentation. The audio and video presentation will be available at the following website address: http://www.firstcallevents.com/service/ajwz399169973gf12.html. It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a replay will be available at this address within 24 hours of the presentation and for a period of 90 days. In addition, Dr. Okarma will be presenting specific information about hESC-derived cardiomyocytes for the treatment of heart disease at a specialty focus meeting. The topic of the Focus Session is "New Approaches to Mending the 'Old Ticker' Are on the Way! An Update on Therapeutic Angiogenesis." The session will be held on Tuesday, February 24, 2004, at 3:30 p.m. Eastern Time. The audio presentation of the Focus Session will be available at the following website address: www.bio.org. It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a replay will be available at this address within 24 hours of the presentation and for a period of 90 days. For further information, please contact Geron Corporation at 650-473-7765, or visit Geron's website at www.geron.com or BIO's website at www.bio.org. Geron is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for cancer based on its telomerase technology, and cell-based therapeutics using its human embryonic stem cell technology. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion